Sort
48,018 grants matching “immunotherapy”
Overcoming resistance to anti-PD1 immunotherapy
$917,690Thomas F Gajewski · University Of Chicago · R35 · FY2019 · CA
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
$917,677Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2023 · CA
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
$917,625Paul M Sondel · University Of Wisconsin-Madison · R35 · FY2016 · CA
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
$917,625Paul M Sondel · University Of Wisconsin-Madison · R35 · FY2015 · CA
Basic Research Support for the CCR
$917,621Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Tfh Cell Plasticity and Heterogeneity in Shaping Immune Responses to Allergy, Infection, and Tolerance
$917,532Andre Ballesteros-Tato · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus
$917,343John M Dye · Geneva Foundation · R01 · FY2017 · AI
Tissue Processing-Sequencing Facility
$917,291Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Next Generation Cancer Immunotherapies to Defeat Melanoma
$917,279Antoni Ribas · University Of California Los Angeles · R35 · FY2023 · CA
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
$917,202Paul M Sondel · University Of Wisconsin-Madison · R35 · FY2017 · CA
Cellular Decision Making
$916,953Orion D Weiner · University Of California, San Francisco · R35 · FY2023 · GM
Cellular Decision Making
$916,953Orion D Weiner · University Of California, San Francisco · R35 · FY2024 · GM
Cellular Decision Making
$916,953Orion D Weiner · University Of California, San Francisco · R35 · FY2022 · GM
Cellular Decision Making
$916,953Orion D Weiner · University Of California, San Francisco · R35 · FY2025 · GM
Cellular Decision Making
$916,953Orion D Weiner · University Of California, San Francisco · R35 · FY2021 · GM
Isolation and Distribution of high quality human pancreatic islets
$916,915Ali Naji · University Of Pennsylvania · U42 · FY2006 · RR
Administrative Core for SWOG SDMC
$916,884Michael Leo Leblanc · Fred Hutchinson Cancer Research Center · U10 · FY2020 · CA
Cytokine Gene Therapy of Cancer - Preclinical Studies
$916,730Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
Cytokine Gene Therapy of Cancer - Preclinical Studies
$916,615Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2006 · CA
Therapy and Prophylaxis for Genital Tract Infection
$915,331Dominick Auci · Therapyx, Inc. · R44 · FY2022 · AI
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
$915,223Paul M Sondel · University Of Wisconsin-Madison · R35 · FY2018 · CA
Development of a safer stem cell-based diabetes therapy via suicide gene-mediated ablation of proliferative cells
$915,136Dena E Cohen · Regenerative Medical Solutions, Inc. · R44 · FY2025 · DK
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$915,096Xihong Lin · Harvard University D/B/A Harvard School Of Public Health · R35 · FY2025 · CA
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
$915,000John F Dipersio · Washington University · R35 · FY2018 · CA
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
$914,906John F Dipersio · Washington University · R35 · FY2020 · CA